In the suggested here linear theory of hydrodynamic instability of the Hagen - Poiseuille flow it is counted the possibility…
The paper describes some concepts on processes occurring in the neuroendocrine and immune systems during development of general unspecific adaptational…
This paper describes a novel approach to the analysis of electrocardiographic data based on the consideration of the repetitive P,…
This paper deals with a study of central hemodynamics in 363 pediatric patients with burn shock as compared with a…
Cardiac allograft vasculopathy (CAV) accounts for major morbidity and mortality late in the heart transplant (HTx) history. The role of antibodies (Abs) directed against human leukocyte antigens (HLA) and non-HLA antigens in the pathogenesis of CAV are still under investigation.
Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.